ALKS 3831

· Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ALKS 3831, covering 2018-06-27 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 [Phase 3]